Adynxx, Inc. is a clinical stage biopharmaceutical company, which engages in the manufacture, development, and sale of novel, disease-modifying products for the treatment of pain and inflammation. The company was founded by Julien Mamet in 2007 and is headquartered in San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Adynxx Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Adynxx Inc market cap is $6.00.
What is the 52-week high for Adynxx Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Adynxx Inc 52 week high is $0.0002 as of February 19, 2026.